Delivery Order SPE2DB24D2100-SPE2DB24FBBJH

Award Date 5/8/24
Potential Completion Date 5/9/24
Potential Value $9.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,184.26 Delivery Order is for the pharmaceutical product Prolia 60 mg/mL syringe. The contract has a Firm Fixed Price pricing type and a completion date of July 16, 2024. It is not associated with a set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distribution companies, holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,260.68 firm fixed-price delivery order is for the supply of Prolia 60 mg/mL syringes. The award has an ultimate completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which...
This federal contract award, valued at $31,381.56, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Prolia 60 mg/ml syringes, a pharmaceutical product, with a period of performance through July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $31,449.70. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to provide PROLIA 60 MG/ML SYRINGEML. The contract has an ultimate completion date of January 27, 2025 and does not have a set-aside designation, indicating it was an open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $42,047.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of PROLIA 60 MG/ML SYRINGEML to the Defense Logistics Agency (DLA). The contract has a ceiling value of $13,887.54 and runs through April 25, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with a ceiling value of $3,572.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Prolia 60 mg/ml syringes, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with a performance period ending on May 7, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,907.80, is for the delivery of Prolia 60 mg/ml syringes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 29, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,409.04 firm fixed-price delivery order is for Prolia 60 mg/ml syringes, a specialty medication used in the treatment of certain medical conditions. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) to provide Prolia 60 mg/ml syringes, a specialty medication, for a firm fixed price of $9,981.92. The award is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to supply a comprehensive range of...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBBJH
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,525.12 firm fixed-price delivery order is for the supply of Prolia 60 mg/mL syringes. The contract has an ultimate completion date of May 9, 2024.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/16/25, 11:46 AM